Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Leonard Seibold

Concepts (197)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glaucoma
35
2025
216
8.370
Why?
Intraocular Pressure
46
2025
296
7.100
Why?
Glaucoma, Open-Angle
20
2023
101
6.670
Why?
Trabeculectomy
16
2025
71
4.570
Why?
Phacoemulsification
13
2025
115
3.890
Why?
Cataract
10
2023
194
2.840
Why?
Ocular Hypertension
7
2022
64
2.680
Why?
Glaucoma Drainage Implants
10
2024
46
2.430
Why?
Tonometry, Ocular
22
2022
88
2.020
Why?
Visual Acuity
12
2024
320
1.990
Why?
Pilocarpine
2
2025
15
1.570
Why?
Trabecular Meshwork
7
2019
79
1.540
Why?
Glaucoma, Angle-Closure
2
2020
16
1.290
Why?
Ophthalmology
4
2023
81
1.150
Why?
Cataract Extraction
5
2020
96
1.120
Why?
Laser Therapy
3
2018
130
1.080
Why?
Ophthalmic Solutions
6
2018
73
0.890
Why?
Filtering Surgery
6
2016
22
0.870
Why?
Antihypertensive Agents
5
2017
486
0.850
Why?
Lens Implantation, Intraocular
3
2018
59
0.830
Why?
Nerve Fibers
2
2012
87
0.740
Why?
Perception
3
2021
337
0.730
Why?
Retinal Ganglion Cells
2
2012
97
0.720
Why?
Tomography, Optical Coherence
2
2012
182
0.680
Why?
Stents
4
2021
504
0.660
Why?
Burnout, Professional
2
2025
408
0.660
Why?
Laser Coagulation
3
2023
57
0.660
Why?
Legislation, Drug
1
2020
81
0.650
Why?
Postoperative Period
7
2025
322
0.650
Why?
Specialization
1
2020
144
0.640
Why?
Remote Sensing Technology
1
2019
16
0.630
Why?
Ciliary Body
2
2018
33
0.620
Why?
Aged, 80 and over
14
2025
7040
0.610
Why?
Medical Marijuana
1
2020
107
0.600
Why?
Angiogenesis Inhibitors
5
2020
216
0.590
Why?
Retrospective Studies
22
2025
14460
0.580
Why?
Brimonidine Tartrate
1
2017
9
0.550
Why?
Thiazines
1
2017
9
0.550
Why?
Timolol
1
2017
14
0.550
Why?
Humans
63
2025
128524
0.550
Why?
Marijuana Use
1
2020
191
0.540
Why?
Marijuana Smoking
1
2020
239
0.540
Why?
Prospective Studies
11
2021
7043
0.540
Why?
Preservatives, Pharmaceutical
2
2013
26
0.530
Why?
Endoscopy
2
2018
267
0.520
Why?
Aged
20
2025
21971
0.520
Why?
Sulfonamides
2
2017
500
0.520
Why?
Corneal Diseases
1
2016
34
0.510
Why?
Endophthalmitis
1
2016
28
0.500
Why?
Circadian Rhythm
2
2023
405
0.500
Why?
Minimally Invasive Surgical Procedures
4
2024
172
0.480
Why?
Middle Aged
21
2025
30893
0.460
Why?
Ocular Hypotension
3
2022
10
0.440
Why?
Cloprostenol
1
2013
13
0.440
Why?
Antibodies, Monoclonal
1
2020
1355
0.430
Why?
Physicians
1
2022
860
0.430
Why?
Prosthesis Implantation
4
2022
143
0.430
Why?
Benzalkonium Compounds
1
2012
15
0.410
Why?
Drug Combinations
3
2020
323
0.400
Why?
Male
27
2025
62883
0.390
Why?
Female
28
2025
68127
0.380
Why?
Treatment Outcome
13
2025
10163
0.360
Why?
Adipocytes
1
2012
204
0.360
Why?
Wound Healing
2
2012
310
0.360
Why?
Stainless Steel
1
2010
23
0.350
Why?
Optic Disk
1
2010
40
0.350
Why?
Blood Pressure
2
2017
1733
0.340
Why?
Contact Lenses
2
2020
8
0.330
Why?
Uveitis
2
2022
127
0.330
Why?
Antineoplastic Agents
1
2020
2058
0.320
Why?
Prednisolone
2
2020
82
0.300
Why?
Follow-Up Studies
6
2025
4898
0.300
Why?
Software
1
2012
610
0.290
Why?
Vision Disorders
2
2020
135
0.280
Why?
Adult
16
2025
35315
0.260
Why?
Reproducibility of Results
4
2024
3023
0.250
Why?
Optometrists
1
2025
4
0.240
Why?
Optometry
1
2025
6
0.240
Why?
Miotics
1
2025
6
0.240
Why?
Cross-Sectional Studies
5
2022
5040
0.240
Why?
Sleep
2
2023
672
0.240
Why?
Muscarinic Agonists
1
2025
16
0.240
Why?
Postoperative Care
2
2025
243
0.230
Why?
Alkylating Agents
2
2016
24
0.230
Why?
Glaucoma, Neovascular
2
2015
10
0.230
Why?
Glucocorticoids
2
2020
575
0.220
Why?
Macular Edema
1
2023
41
0.210
Why?
Surveys and Questionnaires
5
2025
5346
0.210
Why?
Outpatient Clinics, Hospital
1
2023
82
0.200
Why?
Communication Barriers
1
2023
100
0.190
Why?
Diabetic Retinopathy
1
2023
171
0.190
Why?
Heart Rate
2
2017
804
0.180
Why?
Manometry
1
2021
91
0.180
Why?
Cyclopentolate
1
2020
3
0.180
Why?
Microscopy, Acoustic
1
2020
8
0.180
Why?
Gonioscopy
1
2020
6
0.180
Why?
Patient Reported Outcome Measures
1
2024
359
0.180
Why?
Administration, Ophthalmic
1
2020
14
0.180
Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.180
Why?
Vascular Endothelial Growth Factor A
4
2020
501
0.170
Why?
Muscarinic Antagonists
1
2020
26
0.170
Why?
Amyloidosis
1
2020
39
0.170
Why?
Health Status Disparities
1
2023
248
0.170
Why?
Diagnostic Techniques, Ophthalmological
1
2020
38
0.170
Why?
Language
1
2023
283
0.170
Why?
Visual Fields
1
2020
88
0.170
Why?
Eye Diseases
1
2020
78
0.160
Why?
Retinal Diseases
1
2020
86
0.160
Why?
Magnetic Resonance Imaging
2
2014
3366
0.160
Why?
Infusions, Intravenous
1
2020
384
0.160
Why?
Intraoperative Complications
1
2020
132
0.160
Why?
United States
5
2025
13876
0.160
Why?
Preoperative Period
1
2019
113
0.160
Why?
Mitomycin
2
2016
31
0.150
Why?
Young Adult
6
2025
12320
0.150
Why?
Biosensing Techniques
1
2020
114
0.150
Why?
Axial Length, Eye
1
2018
15
0.150
Why?
Corneal Pachymetry
1
2018
14
0.150
Why?
Exfoliation Syndrome
1
2018
10
0.150
Why?
Pseudophakia
1
2018
11
0.150
Why?
Uveitis, Anterior
1
2018
13
0.150
Why?
Time Factors
2
2019
6503
0.150
Why?
Refraction, Ocular
1
2018
36
0.150
Why?
Intravitreal Injections
4
2020
54
0.140
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2016
17
0.140
Why?
Healthcare Disparities
1
2023
576
0.130
Why?
Equipment Design
1
2018
518
0.130
Why?
Fluoroquinolones
1
2016
37
0.130
Why?
Drug Delivery Systems
1
2019
326
0.130
Why?
Coronary Artery Disease
1
2022
677
0.120
Why?
Lasers, Semiconductor
1
2015
12
0.120
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
89
0.120
Why?
Drug Packaging
1
2015
41
0.120
Why?
Device Removal
1
2016
137
0.120
Why?
Ophthalmologic Surgical Procedures
1
2014
56
0.110
Why?
ACTH-Secreting Pituitary Adenoma
1
2014
11
0.110
Why?
Orbital Neoplasms
1
2014
20
0.110
Why?
Travoprost
1
2013
13
0.110
Why?
Patient Preference
1
2016
184
0.110
Why?
Antimetabolites
1
2012
22
0.100
Why?
Quality of Life
1
2024
2680
0.100
Why?
Recombinant Fusion Proteins
1
2015
632
0.100
Why?
Anterior Chamber
1
2012
20
0.100
Why?
Telemedicine
1
2021
778
0.100
Why?
Adenoma
1
2014
214
0.100
Why?
Conjunctiva
1
2012
51
0.100
Why?
Blister
1
2012
40
0.100
Why?
Prostaglandins F
1
2011
17
0.090
Why?
Electromagnetic Fields
1
2010
23
0.090
Why?
Equipment Safety
1
2010
39
0.090
Why?
Medication Adherence
1
2015
573
0.090
Why?
Torque
1
2010
84
0.080
Why?
Tissue Donors
1
2012
386
0.080
Why?
Dexamethasone
1
2012
336
0.080
Why?
Drug Therapy, Combination
1
2012
1009
0.080
Why?
Cell Survival
1
2012
1077
0.080
Why?
Diabetes Mellitus, Type 2
1
2023
2430
0.080
Why?
Reference Values
1
2010
780
0.080
Why?
Cohort Studies
1
2019
5369
0.080
Why?
Immunosuppressive Agents
1
2012
686
0.080
Why?
Adolescent
4
2020
20213
0.070
Why?
Inflammation
1
2018
2664
0.070
Why?
Anti-Bacterial Agents
1
2016
1667
0.060
Why?
Administration, Topical
2
2016
144
0.060
Why?
Cell Proliferation
1
2012
2335
0.060
Why?
Cells, Cultured
1
2012
4008
0.060
Why?
Sickness Impact Profile
1
2024
55
0.060
Why?
Safety-net Providers
1
2023
109
0.050
Why?
Rabbits
2
2012
761
0.040
Why?
Patient Satisfaction
1
2024
644
0.040
Why?
Coronary Angiography
1
2022
306
0.040
Why?
Postoperative Complications
2
2021
2479
0.040
Why?
Ambulatory Care
1
2023
506
0.040
Why?
Attitude
1
2021
250
0.040
Why?
Prevalence
1
2025
2549
0.040
Why?
Histological Techniques
1
2018
39
0.040
Why?
Reoperation
1
2020
550
0.040
Why?
Risk Assessment
2
2020
3256
0.040
Why?
Perioperative Care
1
2019
149
0.040
Why?
Pharmaceutical Preparations
1
2019
170
0.030
Why?
Microscopy
1
2018
140
0.030
Why?
Fibrosis
1
2018
522
0.030
Why?
Medication Errors
1
2015
95
0.030
Why?
Monitoring, Physiologic
1
2016
267
0.030
Why?
Iris
1
2013
19
0.030
Why?
Pilot Projects
1
2018
1558
0.030
Why?
Disease Progression
1
2020
2603
0.030
Why?
Pandemics
1
2021
1487
0.020
Why?
Goblet Cells
1
2012
18
0.020
Why?
Neoplasm Invasiveness
1
2014
480
0.020
Why?
Prognosis
1
2020
3780
0.020
Why?
Neovascularization, Pathologic
1
2013
291
0.020
Why?
Delayed-Action Preparations
1
2012
176
0.020
Why?
Collagen
1
2012
429
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1943
0.020
Why?
Animals
3
2012
34501
0.020
Why?
Child
1
2020
20721
0.010
Why?
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)